Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.

Arroyo-Crespo JJ, Armiñán A, Charbonnier D, Deladriere C, Palomino-Schätzlein M, Lamas-Domingo R, Forteza J, Pineda-Lucena A, Vicent MJ.

Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32270. [Epub ahead of print]

PMID:
30860605
2.

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers.

Gómez-Cebrián N, Rojas-Benedicto A, Albors-Vaquer A, López-Guerrero JA, Pineda-Lucena A, Puchades-Carrasco L.

Metabolites. 2019 Mar 8;9(3). pii: E48. doi: 10.3390/metabo9030048. Review.

3.

EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology.

Brennecke P, Rasina D, Aubi O, Herzog K, Landskron J, Cautain B, Vicente F, Quintana J, Mestres J, Stechmann B, Ellinger B, Brea J, Kolanowski JL, Pilarski R, Orzaez M, Pineda-Lucena A, Laraia L, Nami F, Zielenkiewicz P, Paruch K, Hansen E, von Kries JP, Neuenschwander M, Specker E, Bartunek P, Simova S, Leśnikowski Z, Krauss S, Lehtiö L, Bilitewski U, Brönstrup M, Taskén K, Jirgensons A, Lickert H, Clausen MH, Andersen JH, Vicent MJ, Genilloud O, Martinez A, Nazaré M, Fecke W, Gribbon P.

SLAS Discov. 2019 Mar;24(3):398-413. doi: 10.1177/2472555218816276. Epub 2019 Jan 7.

PMID:
30616481
4.

A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy.

Herance JR, García H, Gutiérrez-Carcedo P, Navalón S, Pineda-Lucena A, Palomino-Schätzlein M.

Analyst. 2019 Feb 11;144(4):1265-1274. doi: 10.1039/c8an01827h.

PMID:
30547176
5.

MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming.

Prieto J, Seo AY, León M, Santacatterina F, Torresano L, Palomino-Schätzlein M, Giménez K, Vallet-Sánchez A, Ponsoda X, Pineda-Lucena A, Cuezva JM, Lippincott-Schwartz J, Torres J.

Stem Cell Reports. 2018 Dec 11;11(6):1479-1492. doi: 10.1016/j.stemcr.2018.10.018. Epub 2018 Nov 21.

6.

Mobilisation Mechanism of Pathogenicity Islands by Endogenous Phages in Staphylococcus aureus clinical strains.

Cervera-Alamar M, Guzmán-Markevitch K, Žiemytė M, Ortí L, Bernabé-Quispe P, Pineda-Lucena A, Pemán J, Tormo-Mas MÁ.

Sci Rep. 2018 Nov 13;8(1):16742. doi: 10.1038/s41598-018-34918-2.

7.

Corrigendum to "A Drosophila model of GDAP1 function reveals the involvement of insulin signalling in the mitochondria-dependent neuromuscular degeneration" [Biochim. Biophys. Acta 1863 (2017) 801-809].

López Del Amo V, Palomino-Schätzlein M, Seco-Cervera M, García-Giménez JL, Pallardó FV, Pineda-Lucena A, Galindo MI.

Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):261. doi: 10.1016/j.bbadis.2018.11.001. Epub 2018 Nov 10. No abstract available.

PMID:
30424922
8.

Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes.

Palomino-Schätzlein M, Simó R, Hernández C, Ciudin A, Mateos-Gregorio P, Hernández-Mijares A, Pineda-Lucena A, Herance JR.

PLoS One. 2018 Jul 13;13(7):e0199351. doi: 10.1371/journal.pone.0199351. eCollection 2018.

9.

Rapid two-dimensional ALSOFAST-HSQC experiment for metabolomics and fluxomics studies: application to a 13C-enriched cancer cell model treated with gold nanoparticles.

Schätzlein MP, Becker J, Schulze-Sünninghausen D, Pineda-Lucena A, Herance JR, Luy B.

Anal Bioanal Chem. 2018 Apr;410(11):2793-2804. doi: 10.1007/s00216-018-0961-6. Epub 2018 Feb 26.

PMID:
29480388
10.

Metabolomics facilitates the discrimination of the specific anti-cancer effects of free- and polymer-conjugated doxorubicin in breast cancer models.

Armiñán A, Palomino-Schätzlein M, Deladriere C, Arroyo-Crespo JJ, Vicente-Ruiz S, Vicent MJ, Pineda-Lucena A.

Biomaterials. 2018 Apr;162:144-153. doi: 10.1016/j.biomaterials.2018.02.015. Epub 2018 Feb 8.

11.

Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Pastor M, Fernández-Calle R, Di Geronimo B, Vicente-Rodríguez M, Zapico JM, Gramage E, Coderch C, Pérez-García C, Lasek AW, Puchades-Carrasco L, Pineda-Lucena A, de Pascual-Teresa B, Herradón G, Ramos A.

Eur J Med Chem. 2018 Jan 20;144:318-329. doi: 10.1016/j.ejmech.2017.11.080. Epub 2017 Nov 28.

12.

Correction: Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis.

Palomino-Schätzlein M, García H, Gutiérrez-Carcedo P, Pineda-Lucena A, Herance JR.

PLoS One. 2017 Dec 11;12(12):e0189748. doi: 10.1371/journal.pone.0189748. eCollection 2017.

13.

Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.

Pérez-Rambla C, Puchades-Carrasco L, García-Flores M, Rubio-Briones J, López-Guerrero JA, Pineda-Lucena A.

Metabolomics. 2017;13(5):52. doi: 10.1007/s11306-017-1194-y. Epub 2017 Mar 9.

14.

Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis.

Palomino-Schätzlein M, García H, Gutiérrez-Carcedo P, Pineda-Lucena A, Herance JR.

PLoS One. 2017 Aug 9;12(8):e0182985. doi: 10.1371/journal.pone.0182985. eCollection 2017. Erratum in: PLoS One. 2017 Dec 11;12 (12 ):e0189748.

15.

Metabolomics Applications in Precision Medicine: An Oncological Perspective.

Puchades-Carrasco L, Pineda-Lucena A.

Curr Top Med Chem. 2017;17(24):2740-2751. doi: 10.2174/1568026617666170707120034. Review.

16.

Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches.

Rombouts FJR, Alexander R, Cleiren E, De Groot A, Carpentier M, Dijkmans J, Fierens K, Masure S, Moechars D, Palomino-Schätzlein M, Pineda-Lucena A, Trabanco AA, Van Glabbeek D, Vos A, Tresadern G.

ACS Omega. 2017 Feb 28;2(2):685-697. doi: 10.1021/acsomega.6b00482. Epub 2017 Feb 24.

17.

The PipX Protein, When Not Bound to Its Targets, Has Its Signaling C-Terminal Helix in a Flexed Conformation.

Forcada-Nadal A, Palomino-Schätzlein M, Neira JL, Pineda-Lucena A, Rubio V.

Biochemistry. 2017 Jun 27;56(25):3211-3224. doi: 10.1021/acs.biochem.7b00230. Epub 2017 Jun 14.

PMID:
28581722
18.

A Drosophila model of GDAP1 function reveals the involvement of insulin signalling in the mitochondria-dependent neuromuscular degeneration.

López Del Amo V, Palomino-Schätzlein M, Seco-Cervera M, García-Giménez JL, Pallardó FV, Pineda-Lucena A, Galindo MI.

Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):801-809. doi: 10.1016/j.bbadis.2017.01.003. Epub 2017 Jan 6. Erratum in: Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):261.

19.

Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients.

Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, Payá V, Pellicer A, Pineda-Lucena A.

Fertil Steril. 2016 Dec;106(7):1733-1741.e1. doi: 10.1016/j.fertnstert.2016.09.014. Epub 2016 Oct 25.

PMID:
27793377
20.

Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme.

Ferruz N, Tresadern G, Pineda-Lucena A, De Fabritiis G.

Sci Rep. 2016 Jul 21;6:30275. doi: 10.1038/srep30275.

Supplemental Content

Loading ...
Support Center